Mioriodol
Brand names,
Mioriodol
Analogs
Mioriodol
Brand Names Mixture
Mioriodol
Chemical_Formula
C12H24N2O4
Mioriodol
RX_link
http://www.rxlist.com/cgi/generic/carisop.htm
Mioriodol
fda sheet
Mioriodol
msds (material safety sheet)
Mioriodol
Synthesis Reference
Berger, Ludwig, U.S. Pat. 2,937,119 (1960)
Mioriodol
Molecular Weight
260.33 g/mol
Mioriodol
Melting Point
92-93 oC
Mioriodol
H2O Solubility
0.3 mg/ml
Mioriodol
State
Solid
Mioriodol
LogP
1.498
Mioriodol
Dosage Forms
Talets
Mioriodol
Indication
For the relief of discomfort associated with acute, painful, musculoskeletal conditions.
Mioriodol
Pharmacology
Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.
Mioriodol
Absorption
No information avaliable
Mioriodol
side effects and Toxicity
Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives
Mioriodol
Patient Information
Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to
strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine
oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or
operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If
dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your
physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin
rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose
therapy.
Mioriodol
Organisms Affected
Humans and other mammals